RU2019112457A - Несольватированный кристалл, способ его получения и его применение - Google Patents
Несольватированный кристалл, способ его получения и его применение Download PDFInfo
- Publication number
- RU2019112457A RU2019112457A RU2019112457A RU2019112457A RU2019112457A RU 2019112457 A RU2019112457 A RU 2019112457A RU 2019112457 A RU2019112457 A RU 2019112457A RU 2019112457 A RU2019112457 A RU 2019112457A RU 2019112457 A RU2019112457 A RU 2019112457A
- Authority
- RU
- Russia
- Prior art keywords
- unsolvated crystal
- naphthaleneformamide
- methoxyquinoline
- aminophenyl
- oxo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610856945.2 | 2016-09-27 | ||
| CN201610856945.2A CN107868044B (zh) | 2016-09-27 | 2016-09-27 | 一种非溶剂化晶体及其制备方法与应用 |
| PCT/CN2017/103620 WO2018059429A1 (zh) | 2016-09-27 | 2017-09-27 | 一种非溶剂化晶体及其制备方法与应用 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2022117574A Division RU2022117574A (ru) | 2016-09-27 | 2017-09-27 | Несольватированный кристалл, способ его получения и его применение |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2019112457A3 RU2019112457A3 (zh) | 2020-11-02 |
| RU2019112457A true RU2019112457A (ru) | 2020-11-02 |
Family
ID=61751435
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2019112457A RU2019112457A (ru) | 2016-09-27 | 2017-09-27 | Несольватированный кристалл, способ его получения и его применение |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US10882825B2 (zh) |
| EP (1) | EP3524594A4 (zh) |
| JP (2) | JP7339884B2 (zh) |
| KR (1) | KR20190053952A (zh) |
| CN (1) | CN107868044B (zh) |
| AU (1) | AU2017333056B2 (zh) |
| BR (1) | BR112019005995A2 (zh) |
| CA (1) | CA3038384C (zh) |
| MX (1) | MX2019003458A (zh) |
| RU (1) | RU2019112457A (zh) |
| TW (1) | TWI724242B (zh) |
| UA (1) | UA123746C2 (zh) |
| WO (1) | WO2018059429A1 (zh) |
| ZA (1) | ZA201902628B (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107868044B (zh) * | 2016-09-27 | 2020-10-16 | 深圳微芯生物科技股份有限公司 | 一种非溶剂化晶体及其制备方法与应用 |
| CN109908143B (zh) * | 2018-12-18 | 2021-11-19 | 厦门大学附属第一医院 | 西奥罗尼在制备治疗急性髓系白血病药物的新用途 |
| TW202140425A (zh) * | 2020-04-21 | 2021-11-01 | 健亞生物科技股份有限公司 | 硫酸羥氯喹之晶體 |
| WO2022052874A1 (zh) * | 2020-09-09 | 2022-03-17 | 深圳微芯生物科技股份有限公司 | 西奥罗尼联合免疫检查点抑制剂在抗肿瘤治疗中的应用 |
| CN117597124A (zh) * | 2021-07-08 | 2024-02-23 | 深圳微芯生物科技股份有限公司 | 西奥罗尼及其联合用药治疗乳腺癌的用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8211901B2 (en) * | 2009-05-22 | 2012-07-03 | Shenzhen Chipscreen Biosciences Ltd. | Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
| CN101906076B (zh) * | 2009-06-04 | 2013-03-13 | 深圳微芯生物科技有限责任公司 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用 |
| CN103833626B (zh) * | 2012-11-27 | 2015-11-25 | 深圳微芯生物科技有限责任公司 | 西达本胺的晶型及其制备方法与应用 |
| CN103288728A (zh) * | 2013-05-17 | 2013-09-11 | 华侨大学 | 一种萘甲酰胺衍生物、其制备方法以及应用 |
| CN103896836A (zh) * | 2014-03-20 | 2014-07-02 | 华侨大学 | N-苯基-6-[(7-氯喹啉-4-氧基)酚醚]-2-萘甲酰胺及其制备方法 |
| CN103923004A (zh) * | 2014-04-04 | 2014-07-16 | 华侨大学 | 一种萘甲酰胺衍生物及其制备和应用 |
| CN107868044B (zh) * | 2016-09-27 | 2020-10-16 | 深圳微芯生物科技股份有限公司 | 一种非溶剂化晶体及其制备方法与应用 |
-
2016
- 2016-09-27 CN CN201610856945.2A patent/CN107868044B/zh active Active
-
2017
- 2017-09-27 TW TW106133220A patent/TWI724242B/zh active
- 2017-09-27 RU RU2019112457A patent/RU2019112457A/ru unknown
- 2017-09-27 US US16/337,389 patent/US10882825B2/en active Active
- 2017-09-27 KR KR1020197012102A patent/KR20190053952A/ko not_active IP Right Cessation
- 2017-09-27 AU AU2017333056A patent/AU2017333056B2/en active Active
- 2017-09-27 JP JP2019517848A patent/JP7339884B2/ja active Active
- 2017-09-27 BR BR112019005995A patent/BR112019005995A2/pt active Search and Examination
- 2017-09-27 MX MX2019003458A patent/MX2019003458A/es unknown
- 2017-09-27 WO PCT/CN2017/103620 patent/WO2018059429A1/zh unknown
- 2017-09-27 CA CA3038384A patent/CA3038384C/en active Active
- 2017-09-27 UA UAA201904447A patent/UA123746C2/uk unknown
- 2017-09-27 EP EP17854879.8A patent/EP3524594A4/en active Pending
-
2019
- 2019-04-25 ZA ZA2019/02628A patent/ZA201902628B/en unknown
-
2021
- 2021-04-07 JP JP2021065323A patent/JP2021105043A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN107868044A (zh) | 2018-04-03 |
| RU2019112457A3 (zh) | 2020-11-02 |
| AU2017333056A1 (en) | 2019-05-02 |
| CN107868044B (zh) | 2020-10-16 |
| ZA201902628B (en) | 2021-09-29 |
| CA3038384A1 (en) | 2018-04-05 |
| AU2017333056B2 (en) | 2020-07-02 |
| EP3524594A1 (en) | 2019-08-14 |
| US20200031774A1 (en) | 2020-01-30 |
| JP2019529504A (ja) | 2019-10-17 |
| JP2021105043A (ja) | 2021-07-26 |
| TWI724242B (zh) | 2021-04-11 |
| JP7339884B2 (ja) | 2023-09-06 |
| US10882825B2 (en) | 2021-01-05 |
| BR112019005995A2 (pt) | 2019-07-09 |
| TW201813957A (zh) | 2018-04-16 |
| UA123746C2 (uk) | 2021-05-26 |
| CA3038384C (en) | 2021-11-02 |
| MX2019003458A (es) | 2019-10-15 |
| WO2018059429A1 (zh) | 2018-04-05 |
| KR20190053952A (ko) | 2019-05-20 |
| EP3524594A4 (en) | 2020-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2019112457A (ru) | Несольватированный кристалл, способ его получения и его применение | |
| RU2599785C3 (ru) | Кристаллические формы 5-хлор-n2-(2-изопропокси-5-метил-4-пиперидин-4-ил-фенил)-n4-[2-(пропан-2-сульфонил)-фенил]-пиримидин-2,4-диамина | |
| Goyanes et al. | 3D printing of medicines: engineering novel oral devices with unique design and drug release characteristics | |
| WO2010040140A3 (en) | Method and apparatus for treating tissues with hifu | |
| RU2009133262A (ru) | Нападизилатная соль антагониста мускаринового мз-рецептора | |
| CA2776342C (en) | Agomelatine and pharmaceutical compositions thereof | |
| RU2009136593A (ru) | Кристаллические формы 6-[2-(метилкарбамоил)фенилсульфанил]-3-е-[2-(пиридин-2-ил)этенил]индазола, пригодные для лечения аномального роста клеток у илекопитаюших | |
| RU2328489C3 (ru) | Кристаллическая форма соли 4-(3-хлор-4-(циклопропиламинокарбонил)аминофенокси)-7-метокси-6-хинолинкарбоксамида или сольвата этой соли и способы ее получения | |
| BRPI0811581A2 (pt) | Estimuladores de sgc, ativadores de sgc e combinações para o tratamento de distúrbios urológicos | |
| JP2014526498A5 (zh) | ||
| JP2016528179A5 (zh) | ||
| RU2012126864A (ru) | Малеатные соли (е)-n-{4-[3-хлор-4-(2-пиридинилметокси)анилино]-3-циано-7-этокси-6-хинолинил}-4-(диметиламино)-2-бутенамида и их кристаллические формы | |
| RU2015143643A (ru) | Соль омекамтива мекарбила и способ ее получения | |
| HRP20141196T1 (hr) | Anhidrirani kristalni oblik orvepitant-maleata | |
| JP2018503649A5 (zh) | ||
| RU2016104396A (ru) | Лекарственные формы, соли и полиморфы транснорсертралина и их применения | |
| JP2021510365A5 (zh) | ||
| JP2005529084A5 (zh) | ||
| RU2022117574A (ru) | Несольватированный кристалл, способ его получения и его применение | |
| RU2018144286A (ru) | Кристалл производного хинолина | |
| RU2015122717A (ru) | 2-пиридоновое соединение | |
| CN112494827A (zh) | 带状疱疹治疗装置 | |
| RU2019114208A (ru) | Кристаллические формы 4-(2-((1r,2r)-2-гидроксициклогексиламино)бензотиазол-6-илокси)-n-метилпиколинамида | |
| AR052881A1 (es) | Formas cristalinas de cis-5-fluoro-n-[4-(2-hidroxi-4-metilbenzamido)ciclohexil]2-tetrahidro-tiopiran-4- iloxi)-nicotinamida con actividad inhibitoria de pde4; composiciones farmaceuticas que las contienen y su uso en la preparacion de un medicamento para el tratamiento de enfermedades inflamatorias | |
| RU2022112633A (ru) | Кристаллические формы биластина и способы их получения |